SCHEMBL1848730

SCHEMBL1848730

[C]1N=CCc2ccccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL153124 0.64
SCHEMBL1162633 0.64 NOS3 (0.36)
SCHEMBL8492495 0.64
SCHEMBL29246 0.64
SCHEMBL976714 0.60 TSHR (0.31)
SCHEMBL15154 0.60 TSHR (0.31)
SCHEMBL416847 0.60 TSHR (0.31)
SCHEMBL518391 0.59 PLAU (0.41)
SCHEMBL29861109 0.59
SCHEMBL60763 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144053-A1 HETEROCYCLIC DERIVATIVES MERCK PATENT GMBH (DE) 2023-08-03 WO claimed
WO-2023090822-A1 NOVEL CANNABICHROMENIC ACID DERIVATIVE, PREPARATION METHOD THEREFOR, AND COMPOSITION COMPRISING SAME FOR IMPROVING COGNITIVE FUNCTION 강원대학교 산학협력단 2023-05-25 WO claimed
EP-3914590-A1 HETEROCYCLIC DERIVATIVES Merck Patent GmbH (DE) 2021-12-01 EP claimed
WO-2020152067-A1 HETEROCYCLIC DERIVATIVES MERCK PATENT GMBH (DE) 2020-07-30 WO claimed
EP-1636216-B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS SANOFI AVENTIS DEUTSCHLAND (DE) 2010-07-21 EP claimed
US-7671051-B2 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1 BIOVITRUM AB (SE) 2010-03-02 US claimed
US-20050250776-A1 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1 BIOVITRUM AB 2005-11-10 US claimed
US-20050187390-A1 Bicyclic heteroaryl derivatives GENELABS TECHNOLOGIES, INC. 2005-08-25 US claimed
EP-1479680-A1 Azaindole derivatives as Factor Xa inhibitors Aventis Pharma Deutschland GmbH (DE) 2004-11-24 EP claimed
EP-0853617-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES Novartis AG (CH) 1998-07-22 EP claimed
EP-0804425-A2 BENZODIAZEPINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-05 EP claimed
WO-1997008155-A1 NOVEL 2,3-DIOXO-1,2,3,4-TETRAHYDRO-QUINOYXALINYL DERIVATIVES NOVARTIS AG (CH) 1997-03-06 WO claimed
US-4855213-A SPECTRA SENSITIZERS EASTMAN KODAK COMPANY (US) 1989-08-08 US claimed
EP-0014880-A1 Phenoxycarboxylic acid amides, process for their preparation and their use as herbicides BAYER AG (DE) 1980-09-03 EP claimed
US-11945799-B2 4-ethynylpyridine derivatives useful as GCN2 inhibitors IP2IPO INNOVATIONS LIMITED (GB) 2024-04-02 US disclosed
EP-4262789-A1 PARASITICIDAL COLLAR COMPRISING ISOXAZOLINE COMPOUNDS Boehringer Ingelheim Vetmedica GmbH (DE) 2023-10-25 EP disclosed
WO-2023196679-A1 2,3-PYRROLIDINEDIONE CONJUGATES AND METHODS OF USING THEREOF NORTH CAROLINA STATE UNIVERSITY (US) 2023-10-12 WO disclosed
EP-0804425-A2 BENZODIAZEPINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-11-05 EP disclosed
WO-1996004254-A2 BENZODIAZEPINE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-02-15 WO disclosed
EP-0284395-A2 Novel glycerol derivative and anti-hypertensive agent NIPPON CHEMIPHAR CO., LTD. (JP) 1988-09-28 EP disclosed